ATE160699T1 - Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung - Google Patents

Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung

Info

Publication number
ATE160699T1
ATE160699T1 AT91911598T AT91911598T ATE160699T1 AT E160699 T1 ATE160699 T1 AT E160699T1 AT 91911598 T AT91911598 T AT 91911598T AT 91911598 T AT91911598 T AT 91911598T AT E160699 T1 ATE160699 T1 AT E160699T1
Authority
AT
Austria
Prior art keywords
production
vaccine against
against swine
swine pneumonia
pneumonia
Prior art date
Application number
AT91911598T
Other languages
English (en)
Inventor
Krishnaswamy I Dayalu
Richard H Peetz
Joseph C Frantz
David S Roberts
Leroy A Swearingin
Richard J Kemmy
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27415051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE160699(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE160699T1 publication Critical patent/ATE160699T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Conductive Materials (AREA)
  • Non-Insulated Conductors (AREA)
AT91911598T 1990-05-29 1991-05-24 Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung ATE160699T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53066990A 1990-05-29 1990-05-29
US57592190A 1990-08-31 1990-08-31
US63423790A 1990-12-26 1990-12-26

Publications (1)

Publication Number Publication Date
ATE160699T1 true ATE160699T1 (de) 1997-12-15

Family

ID=27415051

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91911598T ATE160699T1 (de) 1990-05-29 1991-05-24 Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung

Country Status (10)

Country Link
EP (1) EP0597852B2 (de)
JP (1) JP3187419B2 (de)
AT (1) ATE160699T1 (de)
AU (2) AU657907B2 (de)
CA (1) CA2082155C (de)
DE (1) DE69128361T3 (de)
DK (1) DK0597852T4 (de)
ES (1) ES2112274T5 (de)
GR (1) GR3025937T3 (de)
WO (1) WO1991018627A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
GB9108682D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Production of vaccines
USRE39494E1 (en) * 1992-02-27 2007-02-27 Intervet Inc. Inactivated mycoplasma hyopneumoniae and uses therefor
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
DK0839050T3 (da) * 1992-09-28 2004-10-25 Wyeth Corp Fremgangsmåde til at forstærke celleformidlede immunreaktioner
US5788962A (en) * 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
ES2105984B1 (es) * 1995-11-30 1998-04-16 Iberica Cyanamid Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas.
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2772047B1 (fr) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US6342231B1 (en) * 1998-07-01 2002-01-29 Akzo Nobel N.V. Haemophilus parasuis vaccine and diagnostic
US7172762B1 (en) * 1999-01-29 2007-02-06 Pfizer Inc. Erysipelothrix rhusiopathiae antigens and vaccine compositions
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
DE10010165A1 (de) * 2000-03-01 2001-09-20 Hartmut Merz C O Medizinische Mittel zur Tumorbekämpfung
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY129765A (en) 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
TNSN03155A1 (fr) 2001-07-02 2005-12-23 Pfizer Prod Inc Vaccination unidose avec mycoplasma hyopneumoniae
RU2252785C1 (ru) * 2003-12-29 2005-05-27 Костинов Михаил Петрович Способ профилактики обострений бронхиальной астмы
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US20080226669A1 (en) 2005-12-29 2008-09-18 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
PL2371383T3 (pl) 2005-12-29 2016-01-29 Boehringer Ingelheim Vetmedica Inc Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
CN100419073C (zh) * 2006-09-28 2008-09-17 中国兽医药品监察所 猪喘气病活疫苗及其生产方法
WO2008073464A2 (en) 2006-12-11 2008-06-19 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
ES2625460T5 (es) 2006-12-15 2020-11-04 Boehringer Ingelheim Animal Health Usa Inc Tratamiento de cerdos seropositivos en anticuerpo anti-PCV2 con antígeno de PCV2
EP1941903A1 (de) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxe und Behandlung von PRDC
EP1958644A1 (de) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Vorbeugung und Behandlung von subklinischer PCVD
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
ES2588705T3 (es) 2007-09-27 2016-11-04 Immunovaccine Technologies Inc. Uso de liposomas en un vehículo que comprende una fase hidrófoba continua para la entrega de polinucleótidos in vivo
EP2242511A4 (de) 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed Immunogene pcv2-zusammensetzungen gegen mycoplasma hyopneumoniae und verfahren zur herstellung solcher zusammensetzungen
CA2723918C (en) 2008-06-05 2018-01-09 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
US9107859B2 (en) 2009-09-10 2015-08-18 Merial, Inc. Vaccine formulations comprising saponin-containing adjuvants
IN2014CN02581A (de) 2011-10-06 2015-08-07 Immunovaccine Technologies Inc
CN103182076B (zh) * 2011-12-29 2015-06-17 北京大北农科技集团股份有限公司 一种猪支原体肺炎灭活疫苗及其制备方法
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
EP3049106A1 (de) 2013-09-25 2016-08-03 Zoetis Services LLC Divergente impfstoffzusammensetzung gegen pcv2b und verfahren zur verwendung
DK3052516T3 (da) 2013-10-02 2020-03-23 Boehringer Ingelheim Animal Health Usa Inc PCV2-ORF2-proteinvariant og viruslignende partikler sammensat deraf
CN103585622B (zh) * 2013-11-25 2015-09-02 江苏省农业科学院 猪支原体肺炎疫苗株的应用
CN105288612B (zh) * 2015-10-23 2019-02-26 齐鲁动物保健品有限公司 一种猪伪狂犬病活疫苗-猪支原体肺炎活疫苗组合及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894332A (en) * 1985-03-27 1990-01-16 Biogen, Inc. DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins
IE66690B1 (en) † 1986-05-23 1996-01-24 Oread Pharmaceutical Inc Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US4985243A (en) * 1988-01-20 1991-01-15 Ml Technology Ventures, L.P. Composition and method for protecting against diseases caused by microorganisms
US4895243A (en) * 1988-05-26 1990-01-23 Graham S Neal Starwheel cap selecting apparatus
US4981684A (en) * 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes

Also Published As

Publication number Publication date
EP0597852A1 (de) 1994-05-25
JP3187419B2 (ja) 2001-07-11
JPH05507484A (ja) 1993-10-28
CA2082155C (en) 2008-04-15
AU657907B2 (en) 1995-03-30
CA2082155A1 (en) 1991-11-30
EP0597852A4 (de) 1993-05-11
AU1766295A (en) 1995-10-19
DK0597852T3 (da) 1998-01-12
DK0597852T4 (da) 2005-10-17
ES2112274T3 (es) 1998-04-01
EP0597852B2 (de) 2005-08-10
DE69128361T3 (de) 2006-04-13
DE69128361T2 (de) 1998-07-16
ES2112274T5 (es) 2006-03-01
EP0597852B1 (de) 1997-12-03
GR3025937T3 (en) 1998-04-30
AU7907891A (en) 1991-12-31
WO1991018627A1 (en) 1991-12-12
DE69128361D1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
ATE160699T1 (de) Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung
FR2763244B1 (fr) Composition vaccinale multivalente a porteur mixte
ATE98867T1 (de) Poroese einheitsform und verfahren.
DE69226495D1 (de) Verfahren zur herstellung überzogener mikrobieller pestizide und so hergestellte pestizide
ATE359813T1 (de) Verbesserte i mycoplasma hyopneumoniae /i bacterin vakzine
FI972442A7 (fi) Liukenemista edistävä aine hydrofiilisille makromolekyyleille
DE69411611D1 (de) Biegsam, nicht poröses Rohr und Verfahren zu seiner Herstellung
DE60335010D1 (de) Immunstimulatorische zusammensetzungen und verfahren zur stimulierung einer immunantwort
DE69216133D1 (de) Dünnwandiges Rohr aus ultrahochmolekularem Polyethylen, Verfahren und Vorrichtung zu seiner Herstellung
MX9203243A (es) Oxazolidinonas y composiciones farmaceuticas que las contienen.
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
BR0009663A (pt) Composições de vacinas antibacterianas
FI943483A7 (fi) Oksastettujen funktionalisoitujen polyorganosiloksaanien vesidispersiot, menetelmä niiden valmistamiseksi sekä niiden käyttö kovettuvien silikonikoostumusten valmistamiseen
DE69022346D1 (de) MOS-Feldeffekttransistor und Verfahren zur Herstellung.
DE69112920D1 (de) Elektronentransferanordnung und Verfahren zu dessen Herstellung.
ATE246512T1 (de) Verfahren zur herstellung von inaktivierten, w/ö emulsion adjuvierten, impfstoffen
ES2095874T3 (es) Vacuna acelular.
DE69209336D1 (de) Mikroelektronischer ballistischer Transistor und Verfahren zu seiner Herstellung
DE50214199D1 (de) Bipolartransistor und verfahren zu dessen herstellung
ES2170785T3 (es) Procedimiento para la fabricacion de arilpirroles insecticidas a traves de productos intermedios de oxazolamina.
FI951377A0 (fi) N-asetyylineuramiinihappojohdannaisten synteesi
NO179247C (no) Ikke-ionisk kontrastforbindelse samt radiologisk preparat som omfatter den
KR970700829A (ko) 필름 연신장치의 케리지에 이용하는 완충장치
DE3750549D1 (de) Impfstoff gegen schweinedysenterie.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0597852

Country of ref document: EP

EELA Cancelled due to lapse of time